OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
Yifan Wang, Caixuan Liu, Chao Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Molecular basis of receptor binding and antibody neutralization of Omicron
Hong Qin, Wenyu Han, Jiawei Li, et al.
Nature (2022) Vol. 604, Iss. 7906, pp. 546-552
Open Access | Times Cited: 187

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 187

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
Alexander Muik, Bonny Gaby Lui, Maren Bacher, et al.
Science Immunology (2022) Vol. 7, Iss. 77
Open Access | Times Cited: 68

Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43

Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture
Daniel C. Rabe, Adarsh Choudhury, Dasol Lee, et al.
Science Advances (2025) Vol. 11, Iss. 2
Open Access | Times Cited: 1

Emerging SARS-CoV-2 variants: Why, how, and what's next?
Yu Chen, Qianyun Liu, Li Zhou, et al.
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100029-100029
Open Access | Times Cited: 47

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
Dibya Ghimire, Yang Han, Maolin Lu
Viruses (2022) Vol. 14, Iss. 6, pp. 1255-1255
Open Access | Times Cited: 42

Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 24

Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid
Marco A. Díaz-Salinas, Aastha Jain, Natasha D. Durham, et al.
Science Advances (2024) Vol. 10, Iss. 29
Open Access | Times Cited: 9

Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
Qiong Wang, Sheng‐Bao Ye, Zhijian Zhou, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 28

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
Antoni G. Wrobel
Current Opinion in Structural Biology (2023) Vol. 81, pp. 102619-102619
Open Access | Times Cited: 18

In situ architecture and membrane fusion of SARS-CoV-2 Delta variant
Yutong Song, Hang‐Ping Yao, Nanping Wu, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 18
Open Access | Times Cited: 17

Structure and Dynamics of Alpha B.1.1.7 SARS-CoV-2 S-Protein in complex with Fab of neutralizing antibody REGN10987
Milita V. Kocharovskaya, Evgeny Pichkur, Artem D Ivannikov, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 755, pp. 151558-151558
Closed Access

Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses
Оlga I. Yarovaya, Д. Н. Щербаков, Sophia S. Borisevich, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1295-1295
Open Access | Times Cited: 25

From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
Matteo Pavan, Davide Bassani, Mattia Sturlese, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1704-1714
Open Access | Times Cited: 22

Veklury® (remdesivir) formulations inhibit initial membrane‐coupled events of SARS‐CoV‐2 infection due to their sulfobutylether‐β‐cyclodextrin content
Tamás Kovács, Kitti Kurtan, Zoltán Varga, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 16, pp. 2064-2084
Open Access | Times Cited: 12

AlphaFold2 Predictions of Conformational Ensembles and Atomistic Simulations of the SARS-CoV-2 Spike XBB Lineages Reveal Epistatic Couplings between Convergent Mutational Hotspots that Control ACE2 Affinity
Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, et al.
The Journal of Physical Chemistry B (2024) Vol. 128, Iss. 19, pp. 4696-4715
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top